Amryt Pharma (AMYT) Short Interest Ratio & Short Volume → Biden’s $374B Giveaway Into This Sector (From DTI) (Ad) Free AMYT Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Short InterestStock Analysis Amryt Pharma Short Interest DataCurrent Short Volume229,500 sharesPrevious Short Volume121,200 sharesChange Vs. Previous Month+89.36%Dollar Volume Sold Short$3.35 millionShort Interest Ratio / Days to Cover0.3Last Record DateMarch 31, 2023Outstanding Shares63,960,000 sharesPercentage of Shares Shorted0.36%Today's Trading Volume2,389,400 sharesAverage Trading Volume757,360 sharesToday's Volume Vs. Average315% Short Selling Amryt Pharma ? Sign up to receive the latest short interest report for Amryt Pharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatAMYT Short Interest Over TimeAMYT Days to Cover Over TimeAMYT Percentage of Float Shorted Over Time Ad DTIBiden’s $374B Giveaway Into This SectorBiden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right hereClick here for the full story Amryt Pharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2023229,500 shares $3.35 million +89.4%N/A0.3 $14.58 3/15/2023121,200 shares $1.76 million +56.2%N/A0.2 $14.56 2/28/202377,600 shares $1.13 million +47.5%N/A0.1 $14.61 2/15/202352,600 shares $769,538.00 -6.9%N/A0.1 $14.63 1/31/202356,500 shares $826,595.00 -33.0%N/A0.1 $14.63 1/15/202384,300 shares $1.24 million +41.4%N/A0.2 $14.72 Get the Latest News and Ratings for AMYT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Amryt Pharma and its competitors with MarketBeat's FREE daily newsletter. 12/30/202259,600 shares $435,080.00 -20.5%N/A0.2 $7.30 12/15/202275,000 shares $523,125.00 +9.2%N/A2 $6.98 11/30/202268,700 shares $489,144.00 -22.0%N/A1.9 $7.12 11/15/202288,100 shares $631,677.00 -15.2%N/A2.9 $7.17 10/31/2022103,900 shares $709,637.00 +19.6%N/A3.4 $6.83 10/15/202286,900 shares $590,920.00 -2.9%N/A2.5 $6.80 9/30/202289,500 shares $619,340.00 +17.0%N/A2.1 $6.92 9/15/202276,500 shares $564,570.00 -16.9%N/A1.3 $7.38 8/31/202292,100 shares $667,725.00 -1.4%N/A1.5 $7.25 8/15/202293,400 shares $702,368.00 -5.7%N/A1.3 $7.52 7/31/202299,000 shares $718,740.00 -3.6%N/A1.3 $7.26 7/15/2022102,700 shares $768,196.00 +24.6%N/A1.2 $7.48 6/30/202282,400 shares $575,976.00 -16.4%N/A1 $6.99 6/15/202298,600 shares $699,074.00 -2.0%N/A1.2 $7.09 5/31/2022100,600 shares $804,800.00 -27.2%N/A1.2 $8.00 5/15/2022138,100 shares $1.13 million +78.9%N/A1 $8.21 4/30/202277,200 shares $648,480.00 +8.6%N/A0.5 $8.40 4/15/202271,100 shares $560,268.00 -17.6%N/A0.5 $7.88 3/31/202286,300 shares $713,701.00 -7.0%N/A0.6 $8.27 3/15/202292,800 shares $724,768.00 +28.7%N/A0.6 $7.81 2/28/202272,100 shares $503,258.00 +7.1%N/A0.5 $6.98 2/15/202267,300 shares $634,639.00 -19.0%N/A0.5 $9.43 1/31/202283,100 shares $840,141.00 -15.5%N/A0.7 $10.11 1/15/202298,300 shares $1.04 million +84.8%N/A0.7 $10.55 12/31/202153,200 shares $574,560.00 -25.7%N/A0.4 $10.80 12/15/202171,600 shares $698,816.00 +34.3%N/A0.6 $9.76 11/30/202153,300 shares $529,802.00 -67.0%N/A0.4 $9.94 11/15/2021161,500 shares $1.81 million -30.2%N/A1.3 $11.18 10/29/2021231,300 shares $2.45 million -3.2%N/A1.9 $10.60 10/15/2021238,900 shares $2.81 million -25.0%N/A2 $11.78 9/30/2021318,700 shares $3.84 million -5.0%N/A3 $12.05 9/15/2021335,400 shares $3.80 million -5.9%N/A3.3 $11.33 8/31/2021356,400 shares $3.96 million -25.0%N/A3.7 $11.10 8/13/2021475,100 shares $5.11 million -41.1%N/A4.8 $10.75Could Bitcoin Literally FORCE This Crypto To Rocket Up? (Ad)Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…>>Click here to find out what it is. AMYT Short Interest - Frequently Asked Questions What is Amryt Pharma's current short interest? Short interest is the volume of Amryt Pharma shares that have been sold short but have not yet been covered or closed out. As of March 31st, traders have sold 229,500 shares of AMYT short. Learn More on Amryt Pharma's current short interest. Is Amryt Pharma's short interest increasing or decreasing? Amryt Pharma saw a increase in short interest in March. As of March 31st, there was short interest totaling 229,500 shares, an increase of 89.4% from the previous total of 121,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Amryt Pharma's short interest compare to its competitors? Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Amryt Pharma: Sage Therapeutics, Inc. (17.53%), ABIVAX Société Anonyme (0.27%), Innoviva, Inc. (18.15%), Zentalis Pharmaceuticals, Inc. (21.89%), Cassava Sciences, Inc. (27.26%), Arcutis Biotherapeutics, Inc. (19.89%), ARS Pharmaceuticals, Inc. (13.13%), 89bio, Inc. (12.35%), Liquidia Co. (9.77%), OPKO Health, Inc. (28.56%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.66 billion), TC Energy Co. ($4.13 billion), Occidental Petroleum Co. ($3.04 billion), Moderna, Inc. ($2.63 billion), Coinbase Global, Inc. ($2.51 billion), T. Rowe Price Group, Inc. ($2.29 billion), Paramount Global ($2.26 billion), Verisk Analytics, Inc. ($2.19 billion), Etsy, Inc. ($1.84 billion), and Voya Financial, Inc. ($1.67 billion). View all of the most shorted stocks. What does it mean to sell short Amryt Pharma stock? Short selling AMYT is an investing strategy that aims to generate trading profit from Amryt Pharma as its price is falling. AMYT shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Amryt Pharma? A short squeeze for Amryt Pharma occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AMYT, which in turn drives the price of the stock up even further. How often is Amryt Pharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AMYT, twice per month. The most recent reporting period available is March, 31 2023. More Short Interest Resources from MarketBeat Related Companies: Sage Therapeutics Short Interest ABIVAX Société Anonyme Short Interest Innoviva Short Interest Zentalis Pharmaceuticals Short Interest Cassava Sciences Short Interest Arcutis Biotherapeutics Short Interest ARS Pharmaceuticals Short Interest 89bio Short Interest Liquidia Short Interest OPKO Health Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AMYT) was last updated on 4/18/2024 by MarketBeat.com Staff From Our PartnersDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Urgent!] Generational Wealth GameplanCrypto 101 MediaBiden’s $374B Giveaway Into This SectorDTIThe Next Nvidia?InvestorPlaceOptions trading has suddenly become more reliable.Eagle PublishingTop 5 AI Stocks to Buy for 2024Market Moving TrendsTop 5 Tech Stocks to Buy for 2024Daily Market AlertsUrgent alert: open this for a huge profit potentialTimothy Sykes